 Mark Kearns
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 4 | 2014 | 373 | 0.700 |
Why?
| | Apoptosis | 3 | 2014 | 2444 | 0.460 |
Why?
| | Fas Ligand Protein | 1 | 2014 | 61 | 0.410 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2012 | 56 | 0.350 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 74 | 0.340 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 552 | 0.290 |
Why?
| | Pneumonia | 1 | 2014 | 636 | 0.270 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2014 | 923 | 0.270 |
Why?
| | Lung | 3 | 2014 | 4116 | 0.210 |
Why?
| | Help-Seeking Behavior | 1 | 2021 | 28 | 0.160 |
Why?
| | Patient Positioning | 1 | 2021 | 70 | 0.160 |
Why?
| | Emigration and Immigration | 1 | 2021 | 66 | 0.160 |
Why?
| | Acute Lung Injury | 2 | 2014 | 307 | 0.150 |
Why?
| | Mice, Transgenic | 3 | 2014 | 2191 | 0.140 |
Why?
| | Employment | 1 | 2021 | 184 | 0.140 |
Why?
| | Fear | 1 | 2021 | 368 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 327 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2015 | 5992 | 0.120 |
Why?
| | Social Determinants of Health | 1 | 2021 | 309 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2021 | 714 | 0.110 |
Why?
| | Schistosomiasis mansoni | 1 | 2015 | 25 | 0.110 |
Why?
| | Public Health | 1 | 2021 | 574 | 0.110 |
Why?
| | Interleukin-4 | 1 | 2015 | 207 | 0.110 |
Why?
| | Interleukin-13 | 1 | 2015 | 146 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2014 | 638 | 0.100 |
Why?
| | Curriculum | 1 | 2021 | 1074 | 0.100 |
Why?
| | Adoptive Transfer | 1 | 2014 | 200 | 0.100 |
Why?
| | Endothelial Progenitor Cells | 1 | 2013 | 20 | 0.100 |
Why?
| | Bone Marrow Transplantation | 2 | 2015 | 298 | 0.100 |
Why?
| | Neovascularization, Physiologic | 1 | 2014 | 193 | 0.090 |
Why?
| | Regeneration | 1 | 2014 | 198 | 0.090 |
Why?
| | Jurkat Cells | 1 | 2012 | 115 | 0.090 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.090 |
Why?
| | fas Receptor | 1 | 2011 | 91 | 0.080 |
Why?
| | Emphysema | 1 | 2012 | 100 | 0.080 |
Why?
| | Pulmonary Emphysema | 1 | 2013 | 277 | 0.080 |
Why?
| | Pyrroles | 1 | 2012 | 220 | 0.080 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 858 | 0.080 |
Why?
| | Hospitalization | 1 | 2021 | 2461 | 0.080 |
Why?
| | Radiation Injuries, Experimental | 1 | 2010 | 20 | 0.080 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 523 | 0.080 |
Why?
| | Internship and Residency | 1 | 2021 | 1269 | 0.080 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 435 | 0.080 |
Why?
| | Mice | 5 | 2015 | 18355 | 0.080 |
Why?
| | Gamma Rays | 1 | 2010 | 57 | 0.080 |
Why?
| | Whole-Body Irradiation | 1 | 2010 | 74 | 0.080 |
Why?
| | Indoles | 1 | 2012 | 507 | 0.070 |
Why?
| | Macrophages | 1 | 2015 | 1507 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1146 | 0.060 |
Why?
| | Lung Injury | 1 | 2010 | 249 | 0.060 |
Why?
| | Animals | 6 | 2015 | 38101 | 0.060 |
Why?
| | Cell Line | 1 | 2012 | 2823 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 920 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2933 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1505 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2015 | 1957 | 0.050 |
Why?
| | Sick Leave | 1 | 2021 | 16 | 0.040 |
Why?
| | Prone Position | 1 | 2021 | 25 | 0.040 |
Why?
| | Poverty Areas | 1 | 2021 | 43 | 0.040 |
Why?
| | Social Norms | 1 | 2021 | 31 | 0.040 |
Why?
| | Undocumented Immigrants | 1 | 2021 | 63 | 0.040 |
Why?
| | Health Expenditures | 1 | 2021 | 194 | 0.040 |
Why?
| | California | 1 | 2021 | 473 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1165 | 0.040 |
Why?
| | Social Class | 1 | 2021 | 264 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 554 | 0.030 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 9 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 2015 | 24 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 562 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2015 | 42 | 0.030 |
Why?
| | Smad2 Protein | 1 | 2015 | 37 | 0.030 |
Why?
| | Schistosoma mansoni | 1 | 2015 | 41 | 0.030 |
Why?
| | Th1 Cells | 1 | 2015 | 139 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 702 | 0.030 |
Why?
| | Th17 Cells | 1 | 2015 | 102 | 0.030 |
Why?
| | Humans | 6 | 2021 | 145783 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 181 | 0.030 |
Why?
| | Communication | 1 | 2021 | 977 | 0.030 |
Why?
| | Endothelium | 1 | 2014 | 119 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2015 | 376 | 0.030 |
Why?
| | AC133 Antigen | 1 | 2013 | 20 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 95 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 2013 | 90 | 0.020 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 87 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.020 |
Why?
| | Vascular Remodeling | 1 | 2015 | 209 | 0.020 |
Why?
| | Cell Count | 1 | 2013 | 319 | 0.020 |
Why?
| | Qualitative Research | 1 | 2021 | 1683 | 0.020 |
Why?
| | Bleomycin | 1 | 2014 | 255 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 474 | 0.020 |
Why?
| | Vital Capacity | 1 | 2013 | 292 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 450 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 36309 | 0.020 |
Why?
| | Caspase 8 | 1 | 2011 | 48 | 0.020 |
Why?
| | Glycoproteins | 1 | 2013 | 354 | 0.020 |
Why?
| | Female | 5 | 2021 | 79045 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1708 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4556 | 0.020 |
Why?
| | Radiation Chimera | 1 | 2010 | 28 | 0.020 |
Why?
| | Antigens, CD | 1 | 2013 | 558 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2010 | 107 | 0.020 |
Why?
| | Male | 4 | 2021 | 73010 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 419 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 3130 | 0.020 |
Why?
| | Peptides | 1 | 2013 | 999 | 0.020 |
Why?
| | Adult | 2 | 2021 | 40881 | 0.020 |
Why?
| | Aged | 2 | 2021 | 26217 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1723 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 4151 | 0.010 |
Why?
| | Neutrophils | 1 | 2010 | 1127 | 0.010 |
Why?
| | Inflammation | 1 | 2015 | 2884 | 0.010 |
Why?
| | United States | 1 | 2021 | 16126 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 17330 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4568 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 7134 | 0.010 |
Why?
|
|
Kearns's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|